{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 359.98, "width": 1700, "height": 2200, "unit": "pixel", "lines": [{"boundingBox": [51, 109, 1647, 108, 1648, 132, 52, 133], "text": "inventory write-offs which are included in cost of products sold, related to the Cardiovascular Care business. Additionally, 2011 included higher gains from divestitures and", "words": [{"boundingBox": [52, 111, 141, 110, 140, 133, 52, 132], "text": "inventory"}, {"boundingBox": [145, 110, 237, 110, 237, 133, 144, 133], "text": "write-offs"}, {"boundingBox": [242, 110, 300, 110, 299, 133, 241, 133], "text": "which"}, {"boundingBox": [304, 110, 333, 110, 332, 133, 304, 133], "text": "are"}, {"boundingBox": [337, 110, 418, 110, 418, 133, 337, 133], "text": "included"}, {"boundingBox": [422, 110, 442, 110, 442, 133, 422, 133], "text": "in"}, {"boundingBox": [447, 110, 485, 110, 485, 133, 446, 133], "text": "cost"}, {"boundingBox": [489, 110, 509, 110, 509, 134, 489, 133], "text": "of"}, {"boundingBox": [514, 110, 595, 110, 594, 134, 513, 134], "text": "products"}, {"boundingBox": [599, 110, 645, 110, 644, 134, 599, 134], "text": "sold,"}, {"boundingBox": [649, 110, 713, 110, 713, 134, 648, 134], "text": "related"}, {"boundingBox": [717, 110, 737, 109, 737, 134, 717, 134], "text": "to"}, {"boundingBox": [741, 109, 771, 109, 771, 134, 741, 134], "text": "the"}, {"boundingBox": [776, 109, 918, 109, 918, 134, 775, 134], "text": "Cardiovascular"}, {"boundingBox": [922, 109, 966, 109, 966, 134, 922, 134], "text": "Care"}, {"boundingBox": [971, 109, 1057, 109, 1057, 134, 970, 134], "text": "business."}, {"boundingBox": [1062, 109, 1184, 109, 1184, 134, 1061, 134], "text": "Additionally,"}, {"boundingBox": [1188, 109, 1235, 109, 1235, 133, 1188, 134], "text": "2011"}, {"boundingBox": [1240, 109, 1321, 109, 1321, 133, 1239, 133], "text": "included"}, {"boundingBox": [1325, 109, 1388, 109, 1388, 133, 1325, 133], "text": "higher"}, {"boundingBox": [1392, 109, 1442, 109, 1442, 133, 1392, 133], "text": "gains"}, {"boundingBox": [1446, 109, 1486, 109, 1486, 133, 1446, 133], "text": "from"}, {"boundingBox": [1500, 109, 1604, 109, 1604, 133, 1500, 133], "text": "divestitures"}, {"boundingBox": [1608, 109, 1647, 109, 1647, 132, 1608, 133], "text": "and"}]}, {"boundingBox": [48, 136, 685, 139, 684, 161, 47, 158], "text": "other items of $0.3 billion, recorded in other (income) expense, net.", "words": [{"boundingBox": [50, 138, 99, 138, 100, 158, 50, 158], "text": "other"}, {"boundingBox": [103, 138, 155, 138, 156, 159, 104, 158], "text": "items"}, {"boundingBox": [159, 138, 180, 138, 181, 159, 160, 159], "text": "of"}, {"boundingBox": [184, 138, 226, 138, 226, 160, 185, 159], "text": "$0.3"}, {"boundingBox": [230, 138, 298, 138, 298, 160, 230, 160], "text": "billion,"}, {"boundingBox": [301, 138, 384, 138, 384, 161, 302, 160], "text": "recorded"}, {"boundingBox": [388, 138, 408, 138, 409, 161, 388, 161], "text": "in"}, {"boundingBox": [412, 138, 461, 139, 461, 161, 413, 161], "text": "other"}, {"boundingBox": [465, 139, 551, 139, 552, 161, 465, 161], "text": "(income)"}, {"boundingBox": [555, 139, 636, 140, 636, 161, 556, 161], "text": "expense,"}, {"boundingBox": [639, 140, 683, 140, 683, 161, 640, 161], "text": "net."}]}, {"boundingBox": [91, 162, 1603, 163, 1602, 188, 90, 187], "text": "The 2011 decrease of 27.1% as compared to 2010 was primarily due to costs associated with litigation, which includes product liability, the impact of the OTC and", "words": [{"boundingBox": [94, 163, 128, 163, 129, 186, 94, 186], "text": "The"}, {"boundingBox": [133, 163, 185, 163, 185, 186, 133, 186], "text": "2011"}, {"boundingBox": [189, 163, 265, 164, 265, 187, 190, 186], "text": "decrease"}, {"boundingBox": [269, 164, 290, 164, 291, 187, 270, 187], "text": "of"}, {"boundingBox": [295, 164, 356, 164, 356, 187, 295, 187], "text": "27.1%"}, {"boundingBox": [360, 164, 381, 164, 381, 187, 361, 187], "text": "as"}, {"boundingBox": [385, 164, 478, 165, 478, 188, 386, 187], "text": "compared"}, {"boundingBox": [482, 165, 502, 165, 502, 188, 483, 188], "text": "to"}, {"boundingBox": [506, 165, 554, 165, 554, 188, 506, 188], "text": "2010"}, {"boundingBox": [558, 165, 594, 165, 594, 188, 558, 188], "text": "was"}, {"boundingBox": [598, 165, 689, 165, 689, 188, 599, 188], "text": "primarily"}, {"boundingBox": [695, 165, 725, 165, 725, 188, 695, 188], "text": "due"}, {"boundingBox": [729, 165, 750, 165, 750, 188, 730, 188], "text": "to"}, {"boundingBox": [754, 165, 802, 165, 802, 188, 755, 188], "text": "costs"}, {"boundingBox": [807, 165, 903, 165, 904, 189, 807, 188], "text": "associated"}, {"boundingBox": [908, 165, 948, 165, 948, 189, 908, 189], "text": "with"}, {"boundingBox": [952, 165, 1045, 165, 1045, 189, 953, 189], "text": "litigation,"}, {"boundingBox": [1049, 165, 1106, 165, 1106, 188, 1049, 189], "text": "which"}, {"boundingBox": [1110, 165, 1188, 165, 1188, 188, 1110, 188], "text": "includes"}, {"boundingBox": [1192, 165, 1265, 165, 1265, 188, 1192, 188], "text": "product"}, {"boundingBox": [1269, 165, 1348, 164, 1348, 188, 1270, 188], "text": "liability,"}, {"boundingBox": [1353, 164, 1381, 164, 1381, 188, 1353, 188], "text": "the"}, {"boundingBox": [1385, 164, 1451, 164, 1451, 188, 1386, 188], "text": "impact"}, {"boundingBox": [1455, 164, 1475, 164, 1475, 187, 1456, 188], "text": "of"}, {"boundingBox": [1479, 164, 1510, 164, 1511, 187, 1479, 187], "text": "the"}, {"boundingBox": [1515, 164, 1560, 163, 1560, 187, 1515, 187], "text": "OTC"}, {"boundingBox": [1565, 163, 1603, 163, 1603, 187, 1566, 187], "text": "and"}]}, {"boundingBox": [46, 190, 1642, 191, 1642, 214, 45, 213], "text": "DePuy ASR TM Hip recalls and the restructuring expense related to the Cardiovascular Care business. Additionally, investment spending, the fee on branded pharmaceutical", "words": [{"boundingBox": [49, 191, 114, 191, 115, 214, 50, 214], "text": "DePuy"}, {"boundingBox": [119, 191, 163, 191, 164, 214, 120, 214], "text": "ASR"}, {"boundingBox": [169, 191, 190, 191, 191, 214, 170, 214], "text": "TM"}, {"boundingBox": [195, 191, 229, 191, 230, 214, 195, 214], "text": "Hip"}, {"boundingBox": [234, 191, 296, 191, 297, 214, 235, 214], "text": "recalls"}, {"boundingBox": [300, 191, 335, 191, 336, 214, 301, 214], "text": "and"}, {"boundingBox": [340, 191, 368, 191, 369, 214, 340, 214], "text": "the"}, {"boundingBox": [373, 191, 492, 191, 493, 214, 374, 214], "text": "restructuring"}, {"boundingBox": [497, 191, 571, 191, 572, 214, 498, 214], "text": "expense"}, {"boundingBox": [576, 191, 641, 191, 641, 214, 576, 214], "text": "related"}, {"boundingBox": [645, 191, 665, 191, 666, 214, 646, 214], "text": "to"}, {"boundingBox": [669, 191, 700, 191, 700, 215, 670, 215], "text": "the"}, {"boundingBox": [704, 191, 845, 191, 846, 215, 705, 215], "text": "Cardiovascular"}, {"boundingBox": [849, 191, 893, 191, 894, 215, 850, 215], "text": "Care"}, {"boundingBox": [898, 191, 985, 191, 986, 215, 899, 215], "text": "business."}, {"boundingBox": [990, 191, 1111, 191, 1112, 215, 991, 215], "text": "Additionally,"}, {"boundingBox": [1115, 191, 1220, 191, 1221, 215, 1116, 215], "text": "investment"}, {"boundingBox": [1224, 191, 1313, 191, 1314, 215, 1225, 215], "text": "spending,"}, {"boundingBox": [1318, 191, 1348, 191, 1349, 215, 1319, 215], "text": "the"}, {"boundingBox": [1353, 191, 1381, 191, 1382, 215, 1354, 215], "text": "fee"}, {"boundingBox": [1386, 191, 1410, 191, 1411, 215, 1387, 215], "text": "on"}, {"boundingBox": [1415, 191, 1490, 191, 1491, 215, 1416, 215], "text": "branded"}, {"boundingBox": [1495, 191, 1640, 191, 1641, 215, 1496, 215], "text": "pharmaceutical"}]}, {"boundingBox": [48, 218, 1632, 217, 1632, 242, 49, 243], "text": "products incurred due to the U.S. health care reform legislation, and the integration costs, including an inventory step-up charge, associated with the acquisition of Crucell", "words": [{"boundingBox": [49, 218, 130, 218, 130, 242, 49, 242], "text": "products"}, {"boundingBox": [135, 218, 217, 218, 217, 242, 135, 242], "text": "incurred"}, {"boundingBox": [221, 218, 251, 218, 251, 242, 221, 242], "text": "due"}, {"boundingBox": [256, 218, 275, 218, 275, 242, 256, 242], "text": "to"}, {"boundingBox": [279, 218, 311, 218, 311, 242, 279, 242], "text": "the"}, {"boundingBox": [315, 218, 355, 218, 355, 243, 316, 242], "text": "U.S."}, {"boundingBox": [359, 218, 419, 219, 419, 243, 360, 243], "text": "health"}, {"boundingBox": [424, 219, 461, 219, 462, 243, 424, 243], "text": "care"}, {"boundingBox": [466, 219, 527, 219, 527, 243, 466, 243], "text": "reform"}, {"boundingBox": [535, 219, 639, 219, 639, 243, 535, 243], "text": "legislation,"}, {"boundingBox": [644, 219, 678, 219, 678, 243, 644, 243], "text": "and"}, {"boundingBox": [683, 219, 711, 219, 711, 243, 683, 243], "text": "the"}, {"boundingBox": [716, 219, 818, 219, 818, 243, 716, 243], "text": "integration"}, {"boundingBox": [822, 219, 874, 219, 874, 243, 822, 243], "text": "costs,"}, {"boundingBox": [879, 219, 968, 219, 968, 243, 879, 243], "text": "including"}, {"boundingBox": [973, 219, 995, 219, 995, 243, 973, 243], "text": "an"}, {"boundingBox": [1000, 219, 1091, 219, 1091, 243, 1000, 243], "text": "inventory"}, {"boundingBox": [1096, 219, 1165, 219, 1165, 243, 1095, 243], "text": "step-up"}, {"boundingBox": [1169, 219, 1237, 218, 1237, 243, 1169, 243], "text": "charge,"}, {"boundingBox": [1242, 218, 1339, 218, 1339, 242, 1241, 243], "text": "associated"}, {"boundingBox": [1344, 218, 1384, 218, 1384, 242, 1343, 242], "text": "with"}, {"boundingBox": [1389, 218, 1419, 218, 1419, 242, 1389, 242], "text": "the"}, {"boundingBox": [1424, 218, 1526, 218, 1525, 242, 1423, 242], "text": "acquisition"}, {"boundingBox": [1530, 218, 1551, 218, 1551, 242, 1530, 242], "text": "of"}, {"boundingBox": [1556, 218, 1631, 218, 1631, 241, 1555, 242], "text": "Crucell"}]}, {"boundingBox": [51, 245, 905, 246, 904, 270, 50, 269], "text": "contributed to the decrease in earnings. This was partially offset by gains from divestitures.", "words": [{"boundingBox": [51, 246, 156, 246, 156, 269, 51, 269], "text": "contributed"}, {"boundingBox": [160, 246, 180, 246, 179, 270, 160, 269], "text": "to"}, {"boundingBox": [184, 246, 219, 246, 218, 270, 184, 270], "text": "the"}, {"boundingBox": [223, 246, 299, 246, 299, 270, 223, 270], "text": "decrease"}, {"boundingBox": [304, 246, 325, 246, 324, 270, 303, 270], "text": "in"}, {"boundingBox": [329, 246, 416, 246, 415, 271, 329, 270], "text": "earnings."}, {"boundingBox": [420, 246, 460, 246, 460, 271, 419, 271], "text": "This"}, {"boundingBox": [465, 246, 501, 246, 500, 271, 464, 271], "text": "was"}, {"boundingBox": [505, 246, 584, 246, 583, 271, 504, 271], "text": "partially"}, {"boundingBox": [589, 246, 643, 246, 642, 271, 588, 271], "text": "offset"}, {"boundingBox": [647, 246, 672, 246, 671, 271, 646, 271], "text": "by"}, {"boundingBox": [677, 246, 726, 246, 725, 271, 676, 271], "text": "gains"}, {"boundingBox": [731, 246, 772, 246, 771, 270, 730, 271], "text": "from"}, {"boundingBox": [786, 246, 904, 246, 903, 270, 785, 270], "text": "divestitures."}]}, {"boundingBox": [87, 273, 1233, 272, 1234, 297, 88, 298], "text": "As a percent to sales, consolidated earnings before provision for taxes on income in 2012 was 20.5% versus 19.0% in 201 1.", "words": [{"boundingBox": [92, 274, 118, 274, 120, 296, 93, 296], "text": "As"}, {"boundingBox": [123, 274, 134, 274, 135, 296, 124, 296], "text": "a"}, {"boundingBox": [138, 274, 208, 274, 209, 297, 139, 296], "text": "percent"}, {"boundingBox": [212, 274, 233, 274, 234, 297, 213, 297], "text": "to"}, {"boundingBox": [237, 274, 288, 274, 289, 297, 238, 297], "text": "sales,"}, {"boundingBox": [292, 274, 411, 274, 412, 298, 293, 297], "text": "consolidated"}, {"boundingBox": [415, 274, 494, 274, 495, 298, 416, 298], "text": "earnings"}, {"boundingBox": [498, 274, 558, 274, 559, 298, 499, 298], "text": "before"}, {"boundingBox": [562, 274, 653, 274, 653, 298, 563, 298], "text": "provision"}, {"boundingBox": [657, 274, 685, 274, 685, 298, 658, 298], "text": "for"}, {"boundingBox": [689, 274, 738, 274, 738, 298, 690, 298], "text": "taxes"}, {"boundingBox": [742, 274, 765, 273, 766, 298, 742, 298], "text": "on"}, {"boundingBox": [770, 273, 841, 273, 841, 298, 770, 298], "text": "income"}, {"boundingBox": [845, 273, 864, 273, 865, 298, 845, 298], "text": "in"}, {"boundingBox": [868, 273, 917, 273, 918, 298, 869, 298], "text": "2012"}, {"boundingBox": [921, 273, 959, 273, 959, 297, 922, 298], "text": "was"}, {"boundingBox": [963, 273, 1024, 273, 1025, 297, 963, 297], "text": "20.5%"}, {"boundingBox": [1028, 273, 1090, 273, 1090, 297, 1029, 297], "text": "versus"}, {"boundingBox": [1094, 273, 1154, 273, 1154, 296, 1094, 297], "text": "19.0%"}, {"boundingBox": [1158, 273, 1177, 273, 1178, 296, 1158, 296], "text": "in"}, {"boundingBox": [1182, 273, 1215, 273, 1215, 296, 1182, 296], "text": "201"}, {"boundingBox": [1219, 273, 1233, 273, 1233, 296, 1219, 296], "text": "1."}]}, {"boundingBox": [54, 321, 1631, 322, 1630, 349, 53, 348], "text": "Cost of Products Sold and Selling, Marketing and Administrative Expenses: Cost of products sold and selling, marketing and administrative expenses as a percent to", "words": [{"boundingBox": [55, 322, 97, 323, 96, 347, 54, 346], "text": "Cost"}, {"boundingBox": [102, 323, 120, 323, 120, 347, 101, 347], "text": "of"}, {"boundingBox": [125, 323, 216, 323, 215, 347, 124, 347], "text": "Products"}, {"boundingBox": [221, 323, 265, 323, 264, 348, 220, 347], "text": "Sold"}, {"boundingBox": [269, 323, 308, 323, 308, 348, 269, 348], "text": "and"}, {"boundingBox": [313, 323, 385, 323, 384, 348, 312, 348], "text": "Selling,"}, {"boundingBox": [390, 323, 496, 323, 496, 349, 389, 348], "text": "Marketing"}, {"boundingBox": [501, 323, 540, 324, 540, 349, 500, 349], "text": "and"}, {"boundingBox": [545, 324, 695, 324, 695, 349, 544, 349], "text": "Administrative"}, {"boundingBox": [700, 324, 805, 324, 805, 349, 699, 349], "text": "Expenses:"}, {"boundingBox": [815, 324, 858, 324, 858, 349, 814, 349], "text": "Cost"}, {"boundingBox": [863, 324, 884, 324, 883, 349, 862, 349], "text": "of"}, {"boundingBox": [888, 324, 970, 324, 969, 349, 888, 349], "text": "products"}, {"boundingBox": [974, 324, 1014, 324, 1013, 349, 974, 349], "text": "sold"}, {"boundingBox": [1018, 324, 1053, 324, 1052, 348, 1018, 349], "text": "and"}, {"boundingBox": [1057, 324, 1125, 325, 1124, 348, 1057, 348], "text": "selling,"}, {"boundingBox": [1130, 325, 1225, 325, 1225, 348, 1129, 348], "text": "marketing"}, {"boundingBox": [1230, 325, 1263, 325, 1262, 348, 1229, 348], "text": "and"}, {"boundingBox": [1267, 325, 1402, 325, 1402, 347, 1267, 347], "text": "administrative"}, {"boundingBox": [1407, 325, 1492, 325, 1491, 346, 1406, 347], "text": "expenses"}, {"boundingBox": [1496, 325, 1515, 325, 1514, 346, 1496, 346], "text": "as"}, {"boundingBox": [1520, 325, 1531, 325, 1530, 346, 1519, 346], "text": "a"}, {"boundingBox": [1535, 325, 1604, 325, 1604, 345, 1535, 346], "text": "percent"}, {"boundingBox": [1609, 325, 1631, 325, 1630, 345, 1608, 345], "text": "to"}]}, {"boundingBox": [47, 352, 251, 354, 251, 374, 46, 372], "text": "sales were as follows:", "words": [{"boundingBox": [50, 353, 98, 354, 99, 372, 51, 372], "text": "sales"}, {"boundingBox": [102, 354, 147, 354, 148, 373, 102, 373], "text": "were"}, {"boundingBox": [152, 354, 173, 354, 174, 373, 153, 373], "text": "as"}, {"boundingBox": [176, 354, 250, 354, 251, 374, 177, 373], "text": "follows:"}]}, {"boundingBox": [52, 401, 142, 403, 141, 427, 51, 425], "text": "To of Sales", "words": [{"boundingBox": [57, 402, 73, 403, 73, 425, 57, 424], "text": "To", "confidence": "Low"}, {"boundingBox": [77, 403, 92, 404, 92, 426, 77, 426], "text": "of"}, {"boundingBox": [96, 404, 140, 404, 141, 426, 97, 426], "text": "Sales"}]}, {"boundingBox": [1075, 402, 1120, 401, 1121, 421, 1076, 422], "text": "2012", "words": [{"boundingBox": [1082, 401, 1119, 400, 1120, 420, 1082, 421], "text": "2012"}]}, {"boundingBox": [1306, 403, 1349, 403, 1350, 420, 1307, 420], "text": "2011", "words": [{"boundingBox": [1308, 403, 1347, 403, 1347, 420, 1308, 420], "text": "2011"}]}, {"boundingBox": [1524, 403, 1567, 402, 1568, 419, 1525, 420], "text": "2010", "words": [{"boundingBox": [1530, 402, 1566, 401, 1567, 418, 1530, 419], "text": "2010"}]}, {"boundingBox": [54, 432, 274, 433, 273, 460, 53, 458], "text": "Cost of products sold", "words": [{"boundingBox": [54, 432, 97, 433, 97, 458, 54, 457], "text": "Cost"}, {"boundingBox": [102, 433, 121, 433, 121, 459, 102, 458], "text": "of"}, {"boundingBox": [126, 433, 208, 434, 208, 459, 126, 459], "text": "products"}, {"boundingBox": [213, 434, 258, 434, 257, 458, 213, 459], "text": "sold"}]}, {"boundingBox": [951, 439, 1652, 435, 1653, 457, 952, 461], "text": "32.29313 30.5", "words": [{"boundingBox": [1146, 438, 1419, 437, 1417, 458, 1144, 459], "text": "32.29313", "confidence": "Low"}, {"boundingBox": [1597, 436, 1640, 436, 1638, 458, 1595, 458], "text": "30.5"}]}, {"boundingBox": [53, 466, 430, 465, 431, 490, 54, 491], "text": "Percent point increase over the prior year", "words": [{"boundingBox": [55, 467, 124, 467, 124, 490, 54, 491], "text": "Percent"}, {"boundingBox": [129, 467, 176, 466, 176, 490, 128, 490], "text": "point"}, {"boundingBox": [181, 466, 258, 466, 257, 490, 180, 490], "text": "increase"}, {"boundingBox": [263, 466, 305, 467, 305, 490, 262, 490], "text": "over"}, {"boundingBox": [310, 467, 338, 467, 338, 490, 309, 490], "text": "the"}, {"boundingBox": [343, 467, 390, 467, 390, 490, 342, 490], "text": "prior"}, {"boundingBox": [395, 467, 431, 467, 431, 490, 394, 490], "text": "year"}]}, {"boundingBox": [1153, 468, 1177, 468, 1176, 488, 1152, 488], "text": "0.", "words": [{"boundingBox": [1156, 468, 1176, 468, 1176, 488, 1156, 488], "text": "0.", "confidence": "Low"}]}, {"boundingBox": [1380, 468, 1412, 465, 1411, 487, 1379, 489], "text": "0.8", "words": [{"boundingBox": [1384, 466, 1410, 464, 1412, 486, 1386, 488], "text": "0.8"}]}, {"boundingBox": [1603, 467, 1637, 466, 1637, 488, 1602, 488], "text": "0.7", "words": [{"boundingBox": [1606, 465, 1635, 465, 1635, 487, 1606, 487], "text": "0.7"}]}, {"boundingBox": [56, 497, 502, 500, 501, 527, 56, 525], "text": "Selling, marketing and administrative expenses", "words": [{"boundingBox": [57, 498, 125, 499, 124, 525, 56, 525], "text": "Selling,"}, {"boundingBox": [131, 499, 226, 499, 224, 525, 129, 525], "text": "marketing"}, {"boundingBox": [231, 499, 265, 500, 264, 526, 230, 525], "text": "and"}, {"boundingBox": [271, 500, 403, 501, 402, 527, 269, 526], "text": "administrative"}, {"boundingBox": [409, 501, 500, 501, 499, 528, 407, 527], "text": "expenses"}]}, {"boundingBox": [1110, 496, 1312, 498, 1311, 521, 1110, 520], "text": "310", "words": [{"boundingBox": [1145, 499, 1188, 500, 1187, 520, 1145, 521], "text": "310", "confidence": "Low"}]}, {"boundingBox": [1316, 497, 1649, 499, 1648, 521, 1315, 519], "text": "323 31.5", "words": [{"boundingBox": [1373, 499, 1419, 500, 1417, 518, 1371, 518], "text": "323", "confidence": "Low"}, {"boundingBox": [1597, 500, 1639, 500, 1638, 521, 1596, 520], "text": "31.5"}]}, {"boundingBox": [55, 531, 537, 532, 537, 558, 54, 557], "text": "Percent point (decrease)/increase over the prior year", "words": [{"boundingBox": [55, 532, 123, 532, 123, 558, 55, 558], "text": "Percent"}, {"boundingBox": [128, 532, 177, 532, 176, 557, 128, 558], "text": "point"}, {"boundingBox": [182, 532, 360, 533, 360, 557, 181, 557], "text": "(decrease)/increase"}, {"boundingBox": [365, 533, 405, 533, 405, 558, 365, 557], "text": "over"}, {"boundingBox": [410, 533, 439, 533, 438, 558, 410, 558], "text": "the"}, {"boundingBox": [444, 533, 492, 533, 492, 558, 443, 558], "text": "prior"}, {"boundingBox": [497, 533, 537, 533, 537, 558, 497, 558], "text": "year"}]}, {"boundingBox": [1150, 535, 1193, 533, 1193, 552, 1149, 553], "text": "(1.3)", "words": [{"boundingBox": [1149, 533, 1191, 532, 1191, 551, 1150, 552], "text": "(1.3)"}]}, {"boundingBox": [1382, 531, 1412, 532, 1412, 550, 1381, 549], "text": "0.8", "words": [{"boundingBox": [1385, 531, 1410, 531, 1410, 549, 1385, 549], "text": "0.8"}]}, {"boundingBox": [1603, 536, 1644, 533, 1644, 548, 1603, 550], "text": "0.5)", "words": [{"boundingBox": [1606, 534, 1643, 532, 1644, 547, 1607, 549], "text": "0.5)", "confidence": "Low"}]}, {"boundingBox": [44, 589, 1640, 590, 1640, 613, 43, 613], "text": "In 2012, cost of products sold as a percent to sales increased compared to the prior year. This was primarily the result of the amortization of the inventory step-up charge of", "words": [{"boundingBox": [50, 590, 70, 590, 71, 613, 51, 613], "text": "In"}, {"boundingBox": [75, 590, 127, 590, 128, 613, 76, 613], "text": "2012,"}, {"boundingBox": [132, 590, 171, 590, 172, 613, 133, 613], "text": "cost"}, {"boundingBox": [175, 590, 194, 590, 195, 613, 176, 613], "text": "of"}, {"boundingBox": [199, 590, 281, 590, 282, 613, 200, 613], "text": "products"}, {"boundingBox": [286, 590, 326, 591, 327, 613, 286, 613], "text": "sold"}, {"boundingBox": [331, 591, 351, 591, 352, 613, 331, 613], "text": "as"}, {"boundingBox": [355, 591, 365, 591, 365, 613, 356, 613], "text": "a"}, {"boundingBox": [369, 591, 439, 591, 440, 613, 370, 613], "text": "percent"}, {"boundingBox": [444, 591, 464, 591, 465, 613, 445, 613], "text": "to"}, {"boundingBox": [469, 591, 514, 591, 514, 613, 469, 613], "text": "sales"}, {"boundingBox": [518, 591, 607, 591, 607, 613, 519, 613], "text": "increased"}, {"boundingBox": [611, 591, 705, 591, 705, 613, 612, 613], "text": "compared"}, {"boundingBox": [709, 591, 728, 591, 728, 613, 710, 613], "text": "to"}, {"boundingBox": [732, 591, 760, 591, 761, 613, 733, 613], "text": "the"}, {"boundingBox": [765, 591, 813, 591, 814, 613, 765, 613], "text": "prior"}, {"boundingBox": [818, 591, 867, 591, 868, 613, 818, 613], "text": "year."}, {"boundingBox": [872, 591, 911, 591, 911, 613, 872, 613], "text": "This"}, {"boundingBox": [916, 591, 951, 591, 952, 613, 916, 613], "text": "was"}, {"boundingBox": [956, 591, 1044, 591, 1045, 613, 956, 613], "text": "primarily"}, {"boundingBox": [1049, 591, 1077, 591, 1077, 613, 1049, 613], "text": "the"}, {"boundingBox": [1082, 591, 1136, 591, 1136, 613, 1082, 613], "text": "result"}, {"boundingBox": [1141, 591, 1161, 591, 1161, 613, 1141, 613], "text": "of"}, {"boundingBox": [1165, 591, 1195, 591, 1195, 613, 1165, 613], "text": "the"}, {"boundingBox": [1199, 591, 1316, 591, 1316, 613, 1200, 613], "text": "amortization"}, {"boundingBox": [1321, 591, 1341, 591, 1341, 613, 1321, 613], "text": "of"}, {"boundingBox": [1345, 591, 1375, 591, 1375, 613, 1345, 613], "text": "the"}, {"boundingBox": [1379, 591, 1469, 591, 1469, 613, 1379, 613], "text": "inventory"}, {"boundingBox": [1474, 591, 1544, 591, 1544, 613, 1474, 613], "text": "step-up"}, {"boundingBox": [1549, 591, 1611, 591, 1610, 613, 1548, 613], "text": "charge"}, {"boundingBox": [1615, 591, 1640, 591, 1640, 613, 1615, 613], "text": "of"}]}, {"boundingBox": [54, 615, 1631, 616, 1630, 641, 53, 640], "text": "$0.4 billion and amortization of intangibles related to the Synthes, Inc. acquisition of $0.3 billion and ongoing remediation costs in the McNeil OTC business. There was a", "words": [{"boundingBox": [54, 616, 90, 616, 90, 639, 54, 639], "text": "$0.4", "confidence": "Low"}, {"boundingBox": [94, 616, 158, 616, 158, 640, 95, 639], "text": "billion"}, {"boundingBox": [163, 616, 196, 616, 196, 640, 163, 640], "text": "and"}, {"boundingBox": [200, 616, 318, 616, 319, 640, 201, 640], "text": "amortization"}, {"boundingBox": [323, 616, 344, 616, 344, 640, 323, 640], "text": "of"}, {"boundingBox": [349, 616, 450, 616, 450, 641, 349, 640], "text": "intangibles"}, {"boundingBox": [454, 616, 519, 616, 520, 641, 455, 641], "text": "related"}, {"boundingBox": [524, 616, 542, 616, 542, 641, 524, 641], "text": "to"}, {"boundingBox": [547, 617, 578, 617, 578, 641, 547, 641], "text": "the"}, {"boundingBox": [583, 617, 662, 617, 662, 641, 583, 641], "text": "Synthes,"}, {"boundingBox": [666, 617, 702, 617, 702, 641, 666, 641], "text": "Inc."}, {"boundingBox": [707, 617, 810, 617, 810, 641, 707, 641], "text": "acquisition"}, {"boundingBox": [814, 617, 835, 617, 835, 641, 814, 641], "text": "of"}, {"boundingBox": [840, 617, 881, 617, 881, 641, 840, 641], "text": "$0.3"}, {"boundingBox": [885, 617, 947, 617, 947, 641, 885, 641], "text": "billion"}, {"boundingBox": [952, 617, 987, 617, 986, 641, 952, 641], "text": "and"}, {"boundingBox": [991, 617, 1067, 617, 1067, 641, 991, 641], "text": "ongoing"}, {"boundingBox": [1071, 617, 1185, 618, 1184, 640, 1071, 641], "text": "remediation"}, {"boundingBox": [1189, 618, 1235, 618, 1234, 640, 1189, 640], "text": "costs"}, {"boundingBox": [1239, 618, 1259, 618, 1258, 640, 1239, 640], "text": "in"}, {"boundingBox": [1263, 618, 1292, 618, 1292, 640, 1263, 640], "text": "the"}, {"boundingBox": [1297, 618, 1371, 618, 1370, 640, 1296, 640], "text": "McNeil"}, {"boundingBox": [1375, 618, 1421, 618, 1420, 639, 1375, 640], "text": "OTC"}, {"boundingBox": [1425, 618, 1514, 619, 1514, 639, 1425, 639], "text": "business."}, {"boundingBox": [1519, 619, 1572, 619, 1571, 639, 1518, 639], "text": "There"}, {"boundingBox": [1576, 619, 1613, 619, 1612, 638, 1576, 639], "text": "was"}, {"boundingBox": [1617, 619, 1631, 619, 1630, 638, 1616, 638], "text": "a"}]}, {"boundingBox": [43, 643, 1609, 644, 1608, 670, 42, 669], "text": "decrease in the percent to sales of selling, marketing and administrative expenses in 2012 compared to the prior year primarily due to cost containment initiatives across", "words": [{"boundingBox": [54, 644, 129, 644, 130, 668, 55, 667], "text": "decrease"}, {"boundingBox": [134, 644, 154, 644, 154, 668, 134, 668], "text": "in"}, {"boundingBox": [158, 644, 187, 644, 188, 668, 159, 668], "text": "the"}, {"boundingBox": [192, 644, 261, 644, 262, 668, 193, 668], "text": "percent"}, {"boundingBox": [266, 644, 286, 644, 286, 669, 266, 669], "text": "to"}, {"boundingBox": [290, 644, 336, 644, 337, 669, 291, 669], "text": "sales"}, {"boundingBox": [341, 644, 361, 644, 361, 669, 341, 669], "text": "of"}, {"boundingBox": [365, 644, 433, 644, 433, 669, 366, 669], "text": "selling,"}, {"boundingBox": [437, 644, 534, 644, 534, 670, 438, 669], "text": "marketing"}, {"boundingBox": [538, 644, 574, 644, 574, 670, 539, 670], "text": "and"}, {"boundingBox": [578, 644, 710, 644, 710, 670, 579, 670], "text": "administrative"}, {"boundingBox": [715, 644, 799, 644, 799, 670, 715, 670], "text": "expenses"}, {"boundingBox": [803, 644, 823, 644, 824, 670, 804, 670], "text": "in"}, {"boundingBox": [828, 644, 876, 644, 876, 670, 828, 670], "text": "2012"}, {"boundingBox": [880, 644, 972, 644, 972, 670, 880, 670], "text": "compared"}, {"boundingBox": [977, 644, 995, 644, 995, 670, 977, 670], "text": "to"}, {"boundingBox": [1000, 644, 1029, 644, 1029, 670, 1000, 670], "text": "the"}, {"boundingBox": [1033, 644, 1081, 644, 1081, 670, 1034, 670], "text": "prior"}, {"boundingBox": [1085, 644, 1125, 644, 1126, 669, 1086, 670], "text": "year"}, {"boundingBox": [1130, 644, 1220, 645, 1220, 669, 1130, 669], "text": "primarily"}, {"boundingBox": [1226, 645, 1257, 645, 1257, 669, 1227, 669], "text": "due"}, {"boundingBox": [1262, 645, 1280, 645, 1280, 669, 1262, 669], "text": "to"}, {"boundingBox": [1285, 645, 1323, 645, 1323, 669, 1285, 669], "text": "cost"}, {"boundingBox": [1328, 645, 1443, 645, 1443, 668, 1328, 669], "text": "containment"}, {"boundingBox": [1447, 645, 1541, 645, 1541, 667, 1447, 668], "text": "initiatives"}, {"boundingBox": [1545, 645, 1610, 645, 1610, 667, 1545, 667], "text": "across"}]}, {"boundingBox": [51, 671, 1273, 672, 1272, 697, 50, 696], "text": "many of the businesses. The prior year period included higher investment spending in the Pharmaceutical business for new products.", "words": [{"boundingBox": [51, 673, 102, 673, 101, 696, 51, 696], "text": "many"}, {"boundingBox": [106, 673, 128, 673, 127, 696, 106, 696], "text": "of"}, {"boundingBox": [132, 673, 161, 673, 161, 696, 132, 696], "text": "the"}, {"boundingBox": [166, 673, 272, 672, 272, 696, 165, 696], "text": "businesses."}, {"boundingBox": [277, 672, 311, 672, 311, 696, 276, 696], "text": "The"}, {"boundingBox": [316, 672, 363, 672, 363, 697, 315, 696], "text": "prior"}, {"boundingBox": [368, 672, 408, 672, 407, 697, 367, 697], "text": "year"}, {"boundingBox": [413, 672, 473, 672, 472, 697, 412, 697], "text": "period"}, {"boundingBox": [478, 672, 558, 672, 557, 697, 477, 697], "text": "included"}, {"boundingBox": [563, 672, 623, 672, 622, 697, 562, 697], "text": "higher"}, {"boundingBox": [628, 672, 730, 672, 729, 697, 627, 697], "text": "investment"}, {"boundingBox": [735, 672, 818, 672, 817, 697, 733, 697], "text": "spending"}, {"boundingBox": [823, 672, 843, 672, 842, 697, 821, 697], "text": "in"}, {"boundingBox": [847, 672, 878, 672, 876, 697, 846, 697], "text": "the"}, {"boundingBox": [882, 672, 1025, 672, 1023, 697, 881, 697], "text": "Pharmaceutical"}, {"boundingBox": [1029, 672, 1110, 672, 1109, 697, 1028, 697], "text": "business"}, {"boundingBox": [1115, 672, 1142, 672, 1140, 696, 1113, 697], "text": "for"}, {"boundingBox": [1146, 672, 1184, 673, 1182, 696, 1145, 696], "text": "new"}, {"boundingBox": [1191, 673, 1272, 673, 1270, 696, 1189, 696], "text": "products."}]}, {"boundingBox": [83, 699, 1608, 698, 1608, 724, 84, 725], "text": "In 2011, cost of products sold as a percent to sales increased compared to the prior year. This was primarily attributable to ongoing remediation costs in the McNeil", "words": [{"boundingBox": [91, 699, 113, 699, 113, 722, 90, 722], "text": "In"}, {"boundingBox": [118, 699, 170, 699, 169, 722, 117, 722], "text": "2011,"}, {"boundingBox": [174, 699, 213, 699, 212, 723, 173, 722], "text": "cost"}, {"boundingBox": [217, 699, 238, 699, 237, 723, 216, 723], "text": "of"}, {"boundingBox": [242, 699, 324, 699, 323, 724, 242, 723], "text": "products"}, {"boundingBox": [328, 699, 368, 699, 368, 724, 328, 724], "text": "sold"}, {"boundingBox": [373, 699, 392, 699, 392, 724, 372, 724], "text": "as"}, {"boundingBox": [397, 699, 409, 699, 408, 724, 396, 724], "text": "a"}, {"boundingBox": [413, 699, 481, 699, 481, 725, 412, 724], "text": "percent"}, {"boundingBox": [486, 699, 507, 699, 506, 725, 485, 725], "text": "to"}, {"boundingBox": [511, 699, 556, 699, 555, 725, 510, 725], "text": "sales"}, {"boundingBox": [560, 699, 649, 699, 648, 726, 559, 725], "text": "increased"}, {"boundingBox": [654, 699, 746, 699, 745, 726, 653, 726], "text": "compared"}, {"boundingBox": [750, 699, 769, 699, 768, 726, 749, 726], "text": "to"}, {"boundingBox": [774, 699, 803, 699, 802, 726, 773, 726], "text": "the"}, {"boundingBox": [808, 699, 855, 699, 854, 726, 807, 726], "text": "prior"}, {"boundingBox": [860, 699, 909, 699, 908, 726, 859, 726], "text": "year."}, {"boundingBox": [913, 699, 953, 699, 952, 726, 912, 726], "text": "This"}, {"boundingBox": [958, 699, 993, 699, 992, 726, 957, 726], "text": "was"}, {"boundingBox": [998, 699, 1087, 699, 1086, 725, 997, 726], "text": "primarily"}, {"boundingBox": [1091, 699, 1197, 699, 1196, 725, 1090, 725], "text": "attributable"}, {"boundingBox": [1201, 699, 1221, 699, 1219, 725, 1200, 725], "text": "to"}, {"boundingBox": [1225, 699, 1301, 699, 1299, 724, 1224, 725], "text": "ongoing"}, {"boundingBox": [1305, 699, 1418, 699, 1417, 723, 1304, 724], "text": "remediation"}, {"boundingBox": [1422, 699, 1470, 699, 1469, 723, 1421, 723], "text": "costs"}, {"boundingBox": [1474, 699, 1494, 699, 1492, 723, 1473, 723], "text": "in"}, {"boundingBox": [1498, 699, 1528, 699, 1526, 722, 1497, 723], "text": "the"}, {"boundingBox": [1532, 699, 1608, 699, 1607, 722, 1531, 722], "text": "McNeil"}]}, {"boundingBox": [54, 726, 1648, 727, 1647, 754, 53, 753], "text": "OTC business and inventory write-offs due to the restructuring of the Cardiovascular Care business. In addition, lower margins and integration costs, including an inventory", "words": [{"boundingBox": [54, 728, 97, 728, 97, 753, 54, 753], "text": "OTC"}, {"boundingBox": [102, 728, 181, 728, 181, 753, 102, 753], "text": "business"}, {"boundingBox": [186, 728, 219, 728, 219, 753, 186, 753], "text": "and"}, {"boundingBox": [224, 728, 316, 728, 315, 753, 224, 753], "text": "inventory"}, {"boundingBox": [320, 728, 416, 727, 415, 754, 320, 753], "text": "write-offs"}, {"boundingBox": [420, 727, 449, 727, 448, 754, 420, 754], "text": "due"}, {"boundingBox": [454, 727, 474, 727, 474, 754, 453, 754], "text": "to"}, {"boundingBox": [479, 727, 507, 727, 507, 754, 479, 754], "text": "the"}, {"boundingBox": [512, 727, 631, 727, 631, 754, 512, 754], "text": "restructuring"}, {"boundingBox": [636, 727, 657, 727, 656, 754, 635, 754], "text": "of"}, {"boundingBox": [661, 727, 690, 727, 689, 754, 661, 754], "text": "the"}, {"boundingBox": [695, 727, 836, 727, 835, 754, 694, 754], "text": "Cardiovascular"}, {"boundingBox": [841, 727, 885, 727, 884, 754, 840, 754], "text": "Care"}, {"boundingBox": [890, 727, 975, 727, 974, 754, 889, 754], "text": "business."}, {"boundingBox": [980, 727, 1001, 727, 999, 754, 979, 754], "text": "In"}, {"boundingBox": [1005, 727, 1086, 727, 1085, 754, 1004, 754], "text": "addition,"}, {"boundingBox": [1091, 727, 1147, 727, 1145, 754, 1090, 754], "text": "lower"}, {"boundingBox": [1151, 727, 1227, 727, 1226, 754, 1150, 754], "text": "margins"}, {"boundingBox": [1232, 727, 1266, 727, 1264, 754, 1231, 754], "text": "and"}, {"boundingBox": [1270, 727, 1372, 727, 1370, 754, 1269, 754], "text": "integration"}, {"boundingBox": [1377, 727, 1427, 727, 1425, 754, 1375, 754], "text": "costs,"}, {"boundingBox": [1432, 727, 1522, 727, 1520, 754, 1430, 754], "text": "including"}, {"boundingBox": [1527, 727, 1548, 727, 1546, 754, 1525, 754], "text": "an"}, {"boundingBox": [1553, 727, 1648, 728, 1646, 753, 1551, 754], "text": "inventory"}]}, {"boundingBox": [43, 754, 1580, 755, 1579, 782, 42, 781], "text": "step-up charge, associated with the acquisition of Crucell negatively impacted cost of products sold. Percent to sales of selling, marketing and administrative expenses", "words": [{"boundingBox": [49, 757, 119, 757, 120, 781, 50, 780], "text": "step-up"}, {"boundingBox": [124, 757, 192, 756, 192, 781, 124, 781], "text": "charge,"}, {"boundingBox": [197, 756, 292, 756, 293, 781, 197, 781], "text": "associated"}, {"boundingBox": [297, 756, 340, 756, 340, 781, 297, 781], "text": "with"}, {"boundingBox": [344, 756, 373, 756, 373, 781, 344, 781], "text": "the"}, {"boundingBox": [378, 756, 481, 755, 481, 782, 378, 782], "text": "acquisition"}, {"boundingBox": [485, 755, 505, 755, 505, 782, 486, 782], "text": "of"}, {"boundingBox": [510, 755, 578, 755, 578, 782, 510, 782], "text": "Crucell"}, {"boundingBox": [583, 755, 680, 755, 680, 782, 583, 782], "text": "negatively"}, {"boundingBox": [684, 755, 771, 755, 771, 782, 685, 782], "text": "impacted"}, {"boundingBox": [775, 755, 815, 755, 815, 782, 776, 782], "text": "cost"}, {"boundingBox": [819, 755, 838, 755, 838, 782, 820, 782], "text": "of"}, {"boundingBox": [842, 755, 926, 755, 926, 782, 843, 782], "text": "products"}, {"boundingBox": [930, 755, 974, 755, 975, 782, 931, 782], "text": "sold."}, {"boundingBox": [979, 755, 1049, 755, 1049, 782, 979, 782], "text": "Percent"}, {"boundingBox": [1053, 755, 1073, 755, 1073, 782, 1054, 782], "text": "to"}, {"boundingBox": [1078, 755, 1125, 755, 1125, 782, 1078, 782], "text": "sales"}, {"boundingBox": [1129, 755, 1149, 755, 1149, 782, 1130, 782], "text": "of"}, {"boundingBox": [1154, 755, 1222, 756, 1222, 781, 1154, 782], "text": "selling,"}, {"boundingBox": [1226, 756, 1321, 756, 1321, 781, 1227, 781], "text": "marketing"}, {"boundingBox": [1325, 756, 1360, 756, 1361, 781, 1326, 781], "text": "and"}, {"boundingBox": [1365, 756, 1498, 757, 1499, 780, 1365, 781], "text": "administrative"}, {"boundingBox": [1503, 757, 1579, 757, 1579, 780, 1503, 780], "text": "expenses"}]}, {"boundingBox": [43, 784, 1622, 782, 1622, 808, 44, 809], "text": "increased in 2011 compared to the prior year primarily due to investment spending, as well as the fee on branded pharmaceutical products incurred due to the U.S. health", "words": [{"boundingBox": [48, 785, 136, 784, 137, 808, 49, 807], "text": "increased"}, {"boundingBox": [141, 784, 162, 784, 162, 808, 142, 808], "text": "in"}, {"boundingBox": [166, 784, 214, 784, 214, 808, 167, 808], "text": "2011"}, {"boundingBox": [218, 784, 311, 784, 311, 808, 219, 808], "text": "compared"}, {"boundingBox": [315, 784, 333, 784, 333, 809, 316, 808], "text": "to"}, {"boundingBox": [337, 784, 367, 784, 368, 809, 338, 809], "text": "the"}, {"boundingBox": [372, 784, 419, 784, 420, 809, 372, 809], "text": "prior"}, {"boundingBox": [424, 784, 462, 784, 463, 809, 424, 809], "text": "year"}, {"boundingBox": [467, 784, 558, 784, 558, 809, 467, 809], "text": "primarily"}, {"boundingBox": [564, 784, 595, 784, 595, 809, 564, 809], "text": "due"}, {"boundingBox": [599, 784, 617, 784, 618, 809, 600, 809], "text": "to"}, {"boundingBox": [622, 784, 726, 784, 726, 809, 622, 809], "text": "investment"}, {"boundingBox": [730, 784, 820, 784, 820, 809, 731, 809], "text": "spending,"}, {"boundingBox": [824, 784, 847, 784, 847, 809, 825, 809], "text": "as"}, {"boundingBox": [851, 784, 891, 784, 892, 809, 851, 809], "text": "well"}, {"boundingBox": [896, 784, 915, 784, 915, 809, 896, 809], "text": "as"}, {"boundingBox": [920, 784, 949, 784, 950, 809, 920, 809], "text": "the"}, {"boundingBox": [954, 784, 985, 784, 985, 809, 954, 809], "text": "fee"}, {"boundingBox": [990, 784, 1012, 784, 1012, 809, 990, 809], "text": "on"}, {"boundingBox": [1016, 784, 1092, 784, 1092, 809, 1017, 809], "text": "branded"}, {"boundingBox": [1097, 784, 1238, 784, 1238, 808, 1097, 809], "text": "pharmaceutical"}, {"boundingBox": [1243, 784, 1325, 784, 1325, 808, 1243, 808], "text": "products"}, {"boundingBox": [1329, 784, 1411, 783, 1411, 808, 1329, 808], "text": "incurred"}, {"boundingBox": [1415, 783, 1447, 783, 1447, 807, 1415, 808], "text": "due"}, {"boundingBox": [1451, 783, 1471, 783, 1470, 807, 1451, 807], "text": "to"}, {"boundingBox": [1475, 783, 1505, 783, 1505, 807, 1475, 807], "text": "the"}, {"boundingBox": [1509, 783, 1549, 783, 1549, 807, 1509, 807], "text": "U.S."}, {"boundingBox": [1554, 783, 1615, 783, 1615, 807, 1554, 807], "text": "health"}]}, {"boundingBox": [46, 812, 269, 813, 268, 834, 45, 833], "text": "care reform legislation.", "words": [{"boundingBox": [49, 815, 90, 814, 91, 834, 50, 833], "text": "care"}, {"boundingBox": [93, 814, 151, 813, 152, 834, 94, 834], "text": "reform"}, {"boundingBox": [162, 813, 268, 814, 268, 835, 163, 835], "text": "legislation."}]}, {"boundingBox": [52, 881, 1127, 882, 1126, 906, 51, 905], "text": "Research and Development Expense: Research and development expense by segment of business was as follows:", "words": [{"boundingBox": [52, 882, 141, 883, 142, 905, 53, 904], "text": "Research"}, {"boundingBox": [147, 883, 185, 883, 186, 905, 148, 905], "text": "and"}, {"boundingBox": [190, 883, 322, 883, 323, 906, 191, 905], "text": "Development"}, {"boundingBox": [326, 883, 415, 883, 416, 906, 327, 906], "text": "Expense:"}, {"boundingBox": [420, 883, 506, 884, 507, 906, 421, 906], "text": "Research"}, {"boundingBox": [510, 884, 548, 884, 549, 906, 511, 906], "text": "and"}, {"boundingBox": [553, 884, 671, 884, 672, 906, 554, 906], "text": "development"}, {"boundingBox": [676, 884, 750, 883, 751, 906, 676, 906], "text": "expense"}, {"boundingBox": [755, 883, 779, 883, 780, 906, 755, 906], "text": "by"}, {"boundingBox": [783, 883, 862, 883, 863, 906, 784, 906], "text": "segment"}, {"boundingBox": [867, 883, 887, 883, 888, 906, 868, 906], "text": "of"}, {"boundingBox": [891, 883, 972, 883, 972, 906, 892, 906], "text": "business"}, {"boundingBox": [976, 883, 1013, 883, 1014, 905, 977, 906], "text": "was"}, {"boundingBox": [1018, 882, 1038, 882, 1038, 905, 1018, 905], "text": "as"}, {"boundingBox": [1042, 882, 1127, 882, 1128, 905, 1043, 905], "text": "follows:"}]}, {"boundingBox": [791, 935, 839, 933, 840, 950, 792, 952], "text": "2012", "words": [{"boundingBox": [801, 934, 838, 932, 839, 949, 802, 951], "text": "2012"}]}, {"boundingBox": [1132, 935, 1175, 933, 1175, 950, 1132, 952], "text": "2011", "words": [{"boundingBox": [1139, 934, 1173, 933, 1173, 950, 1139, 951], "text": "2011"}]}, {"boundingBox": [1464, 934, 1509, 933, 1510, 951, 1465, 952], "text": "2010", "words": [{"boundingBox": [1468, 933, 1507, 933, 1508, 951, 1468, 951], "text": "2010"}]}, {"boundingBox": [51, 966, 216, 965, 216, 987, 52, 989], "text": "(Dollars in Millions)", "words": [{"boundingBox": [53, 967, 118, 967, 117, 988, 52, 988], "text": "(Dollars"}, {"boundingBox": [122, 967, 137, 967, 136, 988, 121, 988], "text": "in"}, {"boundingBox": [141, 967, 216, 965, 215, 988, 140, 988], "text": "Millions)"}]}, {"boundingBox": [694, 967, 763, 966, 764, 987, 695, 988], "text": "Amount", "words": [{"boundingBox": [695, 969, 763, 969, 763, 988, 695, 988], "text": "Amount"}]}, {"boundingBox": [853, 967, 945, 963, 946, 984, 854, 988], "text": "To of Sales*", "words": [{"boundingBox": [858, 968, 872, 967, 873, 987, 858, 988], "text": "To", "confidence": "Low"}, {"boundingBox": [876, 967, 893, 966, 893, 986, 876, 987], "text": "of"}, {"boundingBox": [897, 966, 946, 965, 945, 986, 897, 986], "text": "Sales*", "confidence": "Low"}]}, {"boundingBox": [1035, 968, 1101, 965, 1102, 986, 1036, 989], "text": "Amount", "words": [{"boundingBox": [1036, 970, 1102, 968, 1102, 986, 1037, 989], "text": "Amount"}]}, {"boundingBox": [1184, 967, 1282, 964, 1283, 984, 1185, 988], "text": "7% of Sales*", "words": [{"boundingBox": [1190, 968, 1206, 967, 1206, 987, 1190, 988], "text": "7%", "confidence": "Low"}, {"boundingBox": [1210, 967, 1226, 966, 1226, 986, 1210, 987], "text": "of"}, {"boundingBox": [1229, 966, 1283, 965, 1283, 985, 1230, 986], "text": "Sales*", "confidence": "Low"}]}, {"boundingBox": [1359, 966, 1435, 965, 1436, 987, 1360, 988], "text": "Amount", "words": [{"boundingBox": [1365, 968, 1436, 968, 1436, 988, 1365, 988], "text": "Amount"}]}, {"boundingBox": [1510, 967, 1609, 963, 1610, 985, 1510, 988], "text": "of Sales*", "words": [{"boundingBox": [1539, 967, 1556, 967, 1556, 987, 1539, 987], "text": "of"}, {"boundingBox": [1560, 966, 1610, 964, 1610, 985, 1560, 987], "text": "Sales*", "confidence": "Low"}]}, {"boundingBox": [50, 994, 202, 998, 201, 1026, 49, 1022], "text": "Consumer", "words": [{"boundingBox": [54, 996, 157, 997, 156, 1024, 54, 1021], "text": "Consumer"}]}, {"boundingBox": [680, 1000, 784, 995, 786, 1022, 682, 1026], "text": "622", "words": [{"boundingBox": [745, 999, 784, 997, 783, 1022, 744, 1024], "text": "622"}]}, {"boundingBox": [816, 1002, 1646, 999, 1647, 1024, 817, 1026], "text": "431659 4.4 609 42:", "words": [{"boundingBox": [931, 1003, 1127, 1002, 1126, 1026, 930, 1026], "text": "431659", "confidence": "Low"}, {"boundingBox": [1270, 1001, 1300, 1001, 1299, 1026, 1269, 1026], "text": "4.4", "confidence": "Low"}, {"boundingBox": [1420, 1001, 1457, 1002, 1456, 1025, 1419, 1025], "text": "609"}, {"boundingBox": [1601, 1002, 1646, 1002, 1645, 1024, 1600, 1024], "text": "42:", "confidence": "Low"}]}, {"boundingBox": [57, 1029, 202, 1030, 201, 1055, 57, 1055], "text": "Pharmaceutical", "words": [{"boundingBox": [58, 1030, 202, 1032, 202, 1056, 57, 1055], "text": "Pharmaceutical"}]}, {"boundingBox": [726, 1029, 781, 1030, 781, 1053, 726, 1052], "text": "5,362", "words": [{"boundingBox": [729, 1029, 779, 1029, 779, 1052, 728, 1052], "text": "5,362"}]}, {"boundingBox": [916, 1031, 961, 1033, 962, 1054, 916, 1052], "text": "21.2", "words": [{"boundingBox": [920, 1031, 960, 1032, 959, 1053, 919, 1052], "text": "21.2"}]}, {"boundingBox": [1070, 1031, 1124, 1030, 1125, 1053, 1072, 1053], "text": "5,138", "words": [{"boundingBox": [1072, 1029, 1123, 1029, 1123, 1052, 1073, 1052], "text": "5,138"}]}, {"boundingBox": [1255, 1032, 1299, 1031, 1299, 1052, 1255, 1053], "text": "21.1", "words": [{"boundingBox": [1257, 1031, 1297, 1031, 1298, 1052, 1257, 1052], "text": "21.1"}]}, {"boundingBox": [1399, 1029, 1454, 1030, 1453, 1053, 1399, 1052], "text": "4,432", "words": [{"boundingBox": [1403, 1029, 1452, 1029, 1452, 1052, 1403, 1052], "text": "4,432"}]}, {"boundingBox": [1587, 1030, 1632, 1032, 1632, 1052, 1586, 1051], "text": "19.8", "words": [{"boundingBox": [1588, 1029, 1630, 1030, 1630, 1051, 1588, 1050], "text": "19.8"}]}, {"boundingBox": [56, 1062, 374, 1062, 373, 1089, 55, 1088], "text": "Medical Devices and Diagnostics", "words": [{"boundingBox": [56, 1062, 130, 1063, 129, 1089, 56, 1088], "text": "Medical"}, {"boundingBox": [135, 1063, 210, 1063, 209, 1089, 134, 1089], "text": "Devices"}, {"boundingBox": [215, 1063, 250, 1063, 249, 1089, 215, 1089], "text": "and"}, {"boundingBox": [255, 1063, 372, 1064, 370, 1088, 254, 1089], "text": "Diagnostics", "confidence": "Low"}]}, {"boundingBox": [684, 1059, 800, 1058, 801, 1084, 685, 1085], "text": "1.681", "words": [{"boundingBox": [730, 1060, 787, 1059, 786, 1086, 729, 1085], "text": "1.681", "confidence": "Low"}]}, {"boundingBox": [808, 1065, 1029, 1059, 1029, 1084, 809, 1090], "text": "6.1", "words": [{"boundingBox": [932, 1065, 963, 1064, 963, 1086, 931, 1087], "text": "6.1"}]}, {"boundingBox": [1042, 1062, 1260, 1051, 1262, 1078, 1044, 1089], "text": "1.751", "words": [{"boundingBox": [1075, 1061, 1132, 1058, 1131, 1080, 1073, 1086], "text": "1.751", "confidence": "Low"}]}, {"boundingBox": [1128, 1066, 1483, 1057, 1484, 1082, 1129, 1091], "text": "6.8 1,803", "words": [{"boundingBox": [1269, 1063, 1300, 1062, 1299, 1083, 1268, 1084], "text": "6.8"}, {"boundingBox": [1406, 1059, 1456, 1058, 1455, 1083, 1405, 1083], "text": "1,803", "confidence": "Low"}]}, {"boundingBox": [49, 1094, 436, 1095, 435, 1123, 49, 1123], "text": "Total research and development expense", "words": [{"boundingBox": [56, 1095, 102, 1095, 101, 1122, 55, 1123], "text": "Total"}, {"boundingBox": [107, 1095, 186, 1095, 185, 1121, 106, 1122], "text": "research"}, {"boundingBox": [191, 1095, 228, 1095, 228, 1121, 191, 1121], "text": "and"}, {"boundingBox": [234, 1095, 349, 1096, 349, 1122, 233, 1121], "text": "development"}, {"boundingBox": [355, 1096, 436, 1097, 435, 1123, 354, 1122], "text": "expense"}]}, {"boundingBox": [648, 1098, 678, 1097, 677, 1121, 647, 1121], "text": "$", "words": [{"boundingBox": [657, 1096, 676, 1096, 677, 1120, 658, 1120], "text": "$"}]}, {"boundingBox": [727, 1098, 781, 1097, 781, 1118, 727, 1120], "text": "7,665", "words": [{"boundingBox": [729, 1097, 779, 1096, 779, 1118, 729, 1119], "text": "7,665"}]}, {"boundingBox": [923, 1096, 976, 1097, 977, 1118, 924, 1117], "text": "11.4%", "words": [{"boundingBox": [922, 1095, 976, 1096, 975, 1117, 922, 1116], "text": "11.4%"}]}, {"boundingBox": [1075, 1098, 1124, 1096, 1124, 1118, 1075, 1120], "text": "7,548", "words": [{"boundingBox": [1075, 1097, 1122, 1096, 1123, 1118, 1076, 1119], "text": "7,548"}]}, {"boundingBox": [1255, 1099, 1297, 1100, 1297, 1119, 1256, 1118], "text": "11.6", "words": [{"boundingBox": [1258, 1099, 1296, 1099, 1296, 1118, 1258, 1118], "text": "11.6"}]}, {"boundingBox": [1404, 1099, 1453, 1097, 1454, 1118, 1405, 1120], "text": "6,844", "words": [{"boundingBox": [1403, 1099, 1452, 1097, 1452, 1118, 1403, 1120], "text": "6,844"}]}, {"boundingBox": [1585, 1100, 1623, 1101, 1624, 1118, 1586, 1117], "text": "11.1", "words": [{"boundingBox": [1588, 1100, 1623, 1100, 1623, 1117, 1587, 1117], "text": "11.1"}]}, {"boundingBox": [49, 1130, 1282, 1120, 1283, 1150, 50, 1160], "text": "Percent increase/(decrease) over the prior year 16% 103", "words": [{"boundingBox": [54, 1132, 123, 1131, 123, 1159, 53, 1160], "text": "Percent"}, {"boundingBox": [129, 1131, 305, 1129, 305, 1155, 129, 1159], "text": "increase/(decrease)", "confidence": "Low"}, {"boundingBox": [310, 1129, 353, 1129, 352, 1154, 310, 1155], "text": "over"}, {"boundingBox": [358, 1129, 386, 1129, 385, 1154, 358, 1154], "text": "the"}, {"boundingBox": [391, 1129, 437, 1128, 437, 1153, 391, 1153], "text": "prior"}, {"boundingBox": [442, 1128, 492, 1128, 492, 1152, 442, 1153], "text": "year"}, {"boundingBox": [752, 1126, 807, 1126, 807, 1148, 752, 1148], "text": "16%", "confidence": "Low"}, {"boundingBox": [1086, 1126, 1132, 1126, 1132, 1146, 1086, 1146], "text": "103"}]}, {"boundingBox": [1373, 1130, 1629, 1122, 1630, 1146, 1374, 1154], "text": "(2.0)", "words": [{"boundingBox": [1417, 1129, 1472, 1128, 1471, 1148, 1416, 1151], "text": "(2.0)"}]}, {"boundingBox": [52, 1183, 365, 1185, 364, 1211, 51, 1208], "text": "* As a percent to segment sales", "words": [{"boundingBox": [53, 1183, 70, 1183, 70, 1207, 53, 1206], "text": "*"}, {"boundingBox": [86, 1184, 112, 1184, 112, 1208, 86, 1207], "text": "As"}, {"boundingBox": [116, 1184, 127, 1184, 127, 1209, 116, 1208], "text": "a"}, {"boundingBox": [131, 1184, 202, 1185, 201, 1210, 131, 1209], "text": "percent"}, {"boundingBox": [206, 1185, 227, 1185, 227, 1210, 206, 1210], "text": "to"}, {"boundingBox": [232, 1185, 309, 1186, 309, 1210, 231, 1210], "text": "segment"}, {"boundingBox": [314, 1186, 365, 1186, 364, 1208, 313, 1209], "text": "sales"}]}, {"boundingBox": [54, 1236, 1650, 1237, 1650, 1261, 53, 1261], "text": "Research and development activities represent a significant part of the Company's business. These expenditures relate to the processes of discovering, testing and developing", "words": [{"boundingBox": [54, 1237, 136, 1237, 137, 1261, 55, 1261], "text": "Research"}, {"boundingBox": [141, 1237, 179, 1238, 180, 1261, 142, 1261], "text": "and"}, {"boundingBox": [183, 1238, 299, 1238, 300, 1261, 184, 1261], "text": "development"}, {"boundingBox": [303, 1238, 387, 1238, 388, 1261, 304, 1261], "text": "activities"}, {"boundingBox": [392, 1238, 479, 1238, 480, 1262, 393, 1261], "text": "represent"}, {"boundingBox": [483, 1238, 494, 1238, 495, 1262, 484, 1262], "text": "a"}, {"boundingBox": [499, 1238, 597, 1239, 598, 1262, 500, 1262], "text": "significant"}, {"boundingBox": [602, 1239, 640, 1239, 640, 1262, 603, 1262], "text": "part"}, {"boundingBox": [644, 1239, 663, 1239, 664, 1262, 645, 1262], "text": "of"}, {"boundingBox": [668, 1239, 698, 1239, 699, 1262, 669, 1262], "text": "the"}, {"boundingBox": [703, 1239, 805, 1239, 806, 1262, 704, 1262], "text": "Company's"}, {"boundingBox": [810, 1239, 900, 1239, 901, 1262, 811, 1262], "text": "business."}, {"boundingBox": [905, 1239, 958, 1239, 959, 1262, 906, 1262], "text": "These"}, {"boundingBox": [963, 1239, 1080, 1239, 1081, 1262, 964, 1262], "text": "expenditures"}, {"boundingBox": [1085, 1239, 1138, 1239, 1139, 1262, 1085, 1262], "text": "relate"}, {"boundingBox": [1143, 1239, 1162, 1239, 1163, 1262, 1144, 1262], "text": "to"}, {"boundingBox": [1167, 1239, 1195, 1238, 1196, 1262, 1168, 1262], "text": "the"}, {"boundingBox": [1200, 1238, 1290, 1238, 1291, 1262, 1201, 1262], "text": "processes"}, {"boundingBox": [1295, 1238, 1318, 1238, 1319, 1262, 1295, 1262], "text": "of"}, {"boundingBox": [1323, 1238, 1434, 1238, 1434, 1262, 1324, 1262], "text": "discovering,"}, {"boundingBox": [1438, 1238, 1502, 1238, 1502, 1262, 1439, 1262], "text": "testing"}, {"boundingBox": [1506, 1238, 1544, 1238, 1545, 1262, 1507, 1262], "text": "and"}, {"boundingBox": [1549, 1238, 1648, 1237, 1649, 1261, 1549, 1262], "text": "developing"}]}, {"boundingBox": [45, 1264, 1648, 1263, 1648, 1288, 46, 1288], "text": "new products, improving existing products, as well as ensuring product efficacy and regulatory compliance prior to launch. The Company remains committed to investing in", "words": [{"boundingBox": [49, 1265, 88, 1265, 89, 1289, 50, 1289], "text": "new"}, {"boundingBox": [93, 1265, 180, 1265, 180, 1289, 93, 1289], "text": "products,"}, {"boundingBox": [184, 1265, 282, 1265, 283, 1289, 185, 1289], "text": "improving"}, {"boundingBox": [287, 1265, 360, 1265, 361, 1289, 288, 1289], "text": "existing"}, {"boundingBox": [365, 1265, 452, 1265, 453, 1289, 366, 1289], "text": "products,"}, {"boundingBox": [457, 1265, 477, 1265, 477, 1289, 457, 1289], "text": "as"}, {"boundingBox": [482, 1265, 522, 1265, 523, 1289, 482, 1289], "text": "well"}, {"boundingBox": [527, 1265, 547, 1265, 547, 1289, 527, 1289], "text": "as"}, {"boundingBox": [552, 1265, 633, 1265, 633, 1289, 552, 1289], "text": "ensuring"}, {"boundingBox": [637, 1265, 709, 1265, 709, 1289, 638, 1289], "text": "product"}, {"boundingBox": [713, 1265, 790, 1265, 790, 1289, 714, 1289], "text": "efficacy"}, {"boundingBox": [794, 1265, 827, 1265, 827, 1289, 795, 1289], "text": "and"}, {"boundingBox": [832, 1265, 930, 1265, 930, 1289, 832, 1289], "text": "regulatory"}, {"boundingBox": [934, 1265, 1040, 1265, 1041, 1289, 935, 1289], "text": "compliance"}, {"boundingBox": [1045, 1265, 1092, 1265, 1092, 1289, 1045, 1289], "text": "prior"}, {"boundingBox": [1096, 1265, 1115, 1265, 1115, 1289, 1097, 1289], "text": "to"}, {"boundingBox": [1120, 1265, 1191, 1265, 1191, 1289, 1120, 1289], "text": "launch."}, {"boundingBox": [1196, 1265, 1230, 1265, 1230, 1289, 1196, 1289], "text": "The"}, {"boundingBox": [1235, 1265, 1325, 1265, 1325, 1289, 1235, 1289], "text": "Company"}, {"boundingBox": [1330, 1265, 1404, 1264, 1405, 1289, 1330, 1289], "text": "remains"}, {"boundingBox": [1409, 1264, 1509, 1264, 1509, 1289, 1409, 1289], "text": "committed"}, {"boundingBox": [1513, 1264, 1532, 1264, 1532, 1289, 1513, 1289], "text": "to"}, {"boundingBox": [1537, 1264, 1622, 1264, 1622, 1289, 1537, 1289], "text": "investing"}, {"boundingBox": [1627, 1264, 1647, 1264, 1647, 1289, 1627, 1289], "text": "in"}]}, {"boundingBox": [47, 1290, 1608, 1289, 1608, 1315, 48, 1315], "text": "research and development with the aim of delivering high quality and innovative products. In 2012, worldwide costs of research and development activities increased by", "words": [{"boundingBox": [50, 1291, 128, 1291, 127, 1315, 49, 1315], "text": "research"}, {"boundingBox": [133, 1291, 169, 1291, 169, 1315, 132, 1315], "text": "and"}, {"boundingBox": [174, 1291, 292, 1291, 292, 1315, 174, 1315], "text": "development"}, {"boundingBox": [297, 1291, 338, 1291, 338, 1315, 296, 1315], "text": "with"}, {"boundingBox": [343, 1291, 372, 1291, 371, 1315, 343, 1315], "text": "the"}, {"boundingBox": [377, 1291, 410, 1291, 410, 1315, 376, 1315], "text": "aim"}, {"boundingBox": [418, 1291, 440, 1291, 440, 1315, 418, 1315], "text": "of"}, {"boundingBox": [445, 1291, 536, 1290, 536, 1315, 445, 1315], "text": "delivering"}, {"boundingBox": [541, 1290, 584, 1290, 583, 1315, 540, 1315], "text": "high"}, {"boundingBox": [589, 1290, 654, 1290, 654, 1315, 588, 1315], "text": "quality"}, {"boundingBox": [659, 1290, 692, 1290, 692, 1315, 658, 1315], "text": "and"}, {"boundingBox": [697, 1290, 796, 1290, 795, 1315, 697, 1315], "text": "innovative"}, {"boundingBox": [801, 1290, 887, 1290, 886, 1315, 800, 1315], "text": "products."}, {"boundingBox": [891, 1290, 912, 1290, 912, 1315, 891, 1315], "text": "In"}, {"boundingBox": [917, 1290, 971, 1290, 971, 1315, 917, 1315], "text": "2012,"}, {"boundingBox": [976, 1290, 1075, 1291, 1074, 1315, 976, 1315], "text": "worldwide"}, {"boundingBox": [1080, 1291, 1126, 1291, 1125, 1315, 1079, 1315], "text": "costs"}, {"boundingBox": [1131, 1291, 1151, 1291, 1151, 1315, 1130, 1315], "text": "of"}, {"boundingBox": [1156, 1291, 1234, 1291, 1234, 1315, 1156, 1315], "text": "research"}, {"boundingBox": [1239, 1291, 1276, 1291, 1275, 1315, 1239, 1315], "text": "and"}, {"boundingBox": [1280, 1291, 1398, 1291, 1398, 1315, 1280, 1315], "text": "development"}, {"boundingBox": [1403, 1291, 1486, 1291, 1486, 1315, 1403, 1315], "text": "activities"}, {"boundingBox": [1491, 1291, 1578, 1291, 1578, 1315, 1490, 1315], "text": "increased"}, {"boundingBox": [1583, 1291, 1607, 1291, 1607, 1315, 1583, 1315], "text": "by"}]}, {"boundingBox": [49, 1317, 1650, 1318, 1649, 1344, 48, 1343], "text": "1.6% compared to 2011. The decrease in the Medical Devices and Diagnostics segment was primarily due to the discontinuation of the clinical development program for the", "words": [{"boundingBox": [51, 1318, 99, 1318, 100, 1343, 52, 1342], "text": "1.6%"}, {"boundingBox": [103, 1318, 194, 1318, 195, 1343, 104, 1343], "text": "compared"}, {"boundingBox": [199, 1318, 220, 1318, 220, 1343, 200, 1343], "text": "to"}, {"boundingBox": [224, 1318, 278, 1318, 279, 1343, 225, 1343], "text": "2011."}, {"boundingBox": [283, 1318, 321, 1318, 322, 1343, 284, 1343], "text": "The"}, {"boundingBox": [326, 1318, 403, 1318, 403, 1343, 327, 1343], "text": "decrease"}, {"boundingBox": [407, 1318, 427, 1318, 427, 1343, 408, 1343], "text": "in"}, {"boundingBox": [431, 1318, 460, 1318, 461, 1343, 432, 1343], "text": "the"}, {"boundingBox": [465, 1318, 543, 1318, 543, 1344, 465, 1343], "text": "Medical"}, {"boundingBox": [548, 1318, 622, 1318, 623, 1344, 548, 1344], "text": "Devices"}, {"boundingBox": [627, 1318, 661, 1318, 661, 1344, 628, 1344], "text": "and"}, {"boundingBox": [665, 1318, 777, 1318, 777, 1344, 666, 1344], "text": "Diagnostics"}, {"boundingBox": [782, 1318, 860, 1318, 860, 1344, 782, 1344], "text": "segment"}, {"boundingBox": [864, 1318, 901, 1318, 901, 1344, 864, 1344], "text": "was"}, {"boundingBox": [906, 1318, 996, 1318, 996, 1344, 906, 1344], "text": "primarily"}, {"boundingBox": [1001, 1318, 1031, 1318, 1031, 1344, 1001, 1344], "text": "due"}, {"boundingBox": [1036, 1318, 1055, 1318, 1055, 1344, 1036, 1344], "text": "to"}, {"boundingBox": [1060, 1318, 1094, 1318, 1093, 1344, 1060, 1344], "text": "the"}, {"boundingBox": [1098, 1318, 1237, 1318, 1237, 1344, 1098, 1344], "text": "discontinuation"}, {"boundingBox": [1242, 1318, 1262, 1318, 1262, 1344, 1241, 1344], "text": "of"}, {"boundingBox": [1267, 1318, 1297, 1318, 1297, 1344, 1267, 1344], "text": "the"}, {"boundingBox": [1302, 1318, 1374, 1318, 1373, 1344, 1302, 1344], "text": "clinical"}, {"boundingBox": [1379, 1318, 1495, 1318, 1494, 1344, 1378, 1344], "text": "development"}, {"boundingBox": [1500, 1318, 1576, 1318, 1575, 1344, 1499, 1344], "text": "program"}, {"boundingBox": [1584, 1318, 1611, 1318, 1610, 1344, 1583, 1344], "text": "for"}, {"boundingBox": [1616, 1318, 1649, 1318, 1649, 1344, 1615, 1344], "text": "the"}]}, {"boundingBox": [49, 1343, 463, 1345, 462, 1372, 48, 1370], "text": "NEVOTM Sirolimus-Eluting Coronary Stent.", "words": [{"boundingBox": [49, 1346, 138, 1345, 139, 1371, 50, 1371], "text": "NEVOTM"}, {"boundingBox": [143, 1345, 309, 1346, 310, 1372, 144, 1371], "text": "Sirolimus-Eluting"}, {"boundingBox": [314, 1346, 403, 1347, 404, 1372, 315, 1372], "text": "Coronary"}, {"boundingBox": [408, 1347, 461, 1348, 462, 1372, 409, 1372], "text": "Stent."}]}, {"boundingBox": [51, 1399, 1653, 1400, 1652, 1429, 50, 1428], "text": "In-Process Research and Development (IPR&D): In 2012, the Company recorded a charge of $1.2 billion, which included $0.7 billion for the impairment of the IPR&D", "words": [{"boundingBox": [51, 1401, 154, 1401, 155, 1428, 52, 1428], "text": "In-Process"}, {"boundingBox": [160, 1401, 252, 1402, 253, 1428, 160, 1428], "text": "Research"}, {"boundingBox": [257, 1402, 296, 1402, 296, 1428, 258, 1428], "text": "and"}, {"boundingBox": [301, 1402, 432, 1402, 433, 1428, 302, 1428], "text": "Development"}, {"boundingBox": [438, 1402, 537, 1402, 537, 1428, 438, 1428], "text": "(IPR&D):"}, {"boundingBox": [542, 1402, 563, 1402, 564, 1428, 543, 1428], "text": "In"}, {"boundingBox": [569, 1402, 621, 1402, 621, 1428, 569, 1428], "text": "2012,"}, {"boundingBox": [626, 1402, 656, 1402, 656, 1428, 626, 1428], "text": "the"}, {"boundingBox": [661, 1402, 752, 1402, 752, 1428, 661, 1428], "text": "Company"}, {"boundingBox": [757, 1402, 841, 1402, 841, 1428, 757, 1428], "text": "recorded"}, {"boundingBox": [847, 1402, 857, 1402, 857, 1428, 847, 1428], "text": "a"}, {"boundingBox": [862, 1402, 925, 1402, 925, 1428, 862, 1428], "text": "charge"}, {"boundingBox": [931, 1402, 953, 1402, 953, 1428, 930, 1428], "text": "of"}, {"boundingBox": [959, 1402, 997, 1402, 997, 1428, 958, 1428], "text": "$1.2"}, {"boundingBox": [1002, 1402, 1072, 1402, 1072, 1428, 1002, 1428], "text": "billion,"}, {"boundingBox": [1077, 1402, 1133, 1402, 1133, 1429, 1077, 1428], "text": "which"}, {"boundingBox": [1139, 1402, 1221, 1402, 1220, 1429, 1138, 1429], "text": "included"}, {"boundingBox": [1226, 1402, 1266, 1402, 1266, 1429, 1226, 1429], "text": "$0.7"}, {"boundingBox": [1271, 1402, 1334, 1401, 1334, 1429, 1271, 1429], "text": "billion"}, {"boundingBox": [1340, 1401, 1368, 1401, 1367, 1429, 1339, 1429], "text": "for"}, {"boundingBox": [1373, 1401, 1401, 1401, 1400, 1429, 1372, 1429], "text": "the"}, {"boundingBox": [1406, 1401, 1516, 1401, 1516, 1429, 1406, 1429], "text": "impairment"}, {"boundingBox": [1521, 1401, 1541, 1401, 1540, 1429, 1521, 1429], "text": "of"}, {"boundingBox": [1546, 1401, 1576, 1400, 1575, 1429, 1545, 1429], "text": "the"}, {"boundingBox": [1581, 1400, 1653, 1400, 1652, 1429, 1580, 1429], "text": "IPR&D"}]}, {"boundingBox": [46, 1429, 1650, 1428, 1650, 1455, 47, 1456], "text": "related to the discontinuation of the Phase III clinical development of bapineuzumab IV and the partial impairment of the IPR&D related to the Crucell vaccine business in", "words": [{"boundingBox": [50, 1430, 115, 1430, 114, 1455, 49, 1455], "text": "related"}, {"boundingBox": [120, 1430, 138, 1430, 137, 1455, 119, 1455], "text": "to"}, {"boundingBox": [143, 1430, 176, 1430, 176, 1455, 142, 1455], "text": "the"}, {"boundingBox": [181, 1430, 323, 1430, 322, 1456, 181, 1455], "text": "discontinuation"}, {"boundingBox": [328, 1430, 348, 1430, 347, 1456, 327, 1456], "text": "of"}, {"boundingBox": [353, 1430, 383, 1430, 383, 1456, 352, 1456], "text": "the"}, {"boundingBox": [388, 1430, 443, 1430, 443, 1456, 388, 1456], "text": "Phase"}, {"boundingBox": [448, 1430, 473, 1430, 473, 1456, 448, 1456], "text": "III"}, {"boundingBox": [478, 1430, 552, 1430, 551, 1456, 478, 1456], "text": "clinical"}, {"boundingBox": [557, 1430, 674, 1430, 673, 1456, 556, 1456], "text": "development"}, {"boundingBox": [679, 1430, 699, 1430, 698, 1456, 678, 1456], "text": "of"}, {"boundingBox": [704, 1430, 841, 1430, 840, 1456, 703, 1456], "text": "bapineuzumab"}, {"boundingBox": [846, 1430, 874, 1430, 873, 1456, 845, 1456], "text": "IV"}, {"boundingBox": [879, 1430, 912, 1430, 912, 1457, 878, 1456], "text": "and"}, {"boundingBox": [917, 1430, 947, 1430, 947, 1457, 917, 1457], "text": "the"}, {"boundingBox": [952, 1430, 1012, 1430, 1012, 1457, 952, 1457], "text": "partial"}, {"boundingBox": [1017, 1430, 1126, 1430, 1125, 1456, 1017, 1457], "text": "impairment"}, {"boundingBox": [1131, 1430, 1153, 1430, 1152, 1456, 1130, 1456], "text": "of"}, {"boundingBox": [1158, 1430, 1186, 1430, 1185, 1456, 1157, 1456], "text": "the"}, {"boundingBox": [1191, 1430, 1263, 1430, 1262, 1456, 1190, 1456], "text": "IPR&D"}, {"boundingBox": [1268, 1430, 1333, 1430, 1332, 1456, 1267, 1456], "text": "related"}, {"boundingBox": [1338, 1430, 1358, 1430, 1357, 1456, 1337, 1456], "text": "to"}, {"boundingBox": [1363, 1429, 1393, 1429, 1392, 1456, 1362, 1456], "text": "the"}, {"boundingBox": [1398, 1429, 1468, 1429, 1467, 1456, 1397, 1456], "text": "Crucell"}, {"boundingBox": [1473, 1429, 1543, 1429, 1543, 1456, 1472, 1456], "text": "vaccine"}, {"boundingBox": [1548, 1429, 1628, 1429, 1628, 1456, 1548, 1456], "text": "business"}, {"boundingBox": [1633, 1429, 1650, 1429, 1649, 1456, 1633, 1456], "text": "in"}]}, {"boundingBox": [44, 1455, 1654, 1456, 1653, 1483, 43, 1482], "text": "the amount of $0.4 billion. Of the $0.7 billion impairment of the IPR&D related to the discontinuation of the Phase III clinical development of bapineuzumab IV, $0.3", "words": [{"boundingBox": [49, 1457, 82, 1458, 82, 1481, 49, 1481], "text": "the"}, {"boundingBox": [86, 1458, 159, 1458, 159, 1482, 87, 1481], "text": "amount"}, {"boundingBox": [164, 1458, 187, 1458, 187, 1482, 164, 1482], "text": "of"}, {"boundingBox": [192, 1458, 234, 1458, 234, 1482, 192, 1482], "text": "$0.4"}, {"boundingBox": [238, 1458, 310, 1458, 310, 1482, 239, 1482], "text": "billion."}, {"boundingBox": [314, 1458, 342, 1458, 342, 1482, 315, 1482], "text": "Of"}, {"boundingBox": [347, 1458, 380, 1458, 380, 1482, 347, 1482], "text": "the"}, {"boundingBox": [384, 1458, 426, 1458, 426, 1482, 384, 1482], "text": "$0.7"}, {"boundingBox": [431, 1458, 495, 1458, 494, 1483, 431, 1482], "text": "billion"}, {"boundingBox": [499, 1458, 611, 1458, 611, 1483, 499, 1483], "text": "impairment"}, {"boundingBox": [616, 1458, 637, 1458, 637, 1483, 615, 1483], "text": "of"}, {"boundingBox": [642, 1458, 675, 1458, 674, 1483, 642, 1483], "text": "the"}, {"boundingBox": [679, 1458, 748, 1458, 747, 1483, 679, 1483], "text": "IPR&D"}, {"boundingBox": [757, 1458, 824, 1458, 823, 1483, 757, 1483], "text": "related"}, {"boundingBox": [828, 1458, 850, 1458, 850, 1483, 828, 1483], "text": "to"}, {"boundingBox": [855, 1458, 889, 1458, 888, 1483, 854, 1483], "text": "the"}, {"boundingBox": [895, 1458, 1038, 1458, 1037, 1483, 895, 1483], "text": "discontinuation"}, {"boundingBox": [1043, 1458, 1066, 1458, 1065, 1483, 1042, 1483], "text": "of"}, {"boundingBox": [1070, 1458, 1102, 1458, 1101, 1483, 1070, 1483], "text": "the"}, {"boundingBox": [1106, 1458, 1164, 1458, 1163, 1483, 1106, 1483], "text": "Phase"}, {"boundingBox": [1168, 1458, 1195, 1458, 1194, 1483, 1168, 1483], "text": "III"}, {"boundingBox": [1199, 1458, 1275, 1457, 1275, 1483, 1199, 1483], "text": "clinical"}, {"boundingBox": [1280, 1457, 1400, 1457, 1399, 1483, 1279, 1483], "text": "development"}, {"boundingBox": [1404, 1457, 1426, 1457, 1425, 1483, 1403, 1483], "text": "of"}, {"boundingBox": [1431, 1457, 1569, 1456, 1568, 1483, 1430, 1483], "text": "bapineuzumab"}, {"boundingBox": [1573, 1456, 1608, 1456, 1607, 1483, 1572, 1483], "text": "IV,"}, {"boundingBox": [1612, 1456, 1654, 1456, 1653, 1483, 1611, 1483], "text": "$0.3"}]}, {"boundingBox": [54, 1489, 106, 1490, 107, 1509, 53, 1508], "text": "billion", "words": [{"boundingBox": [52, 1488, 106, 1489, 105, 1508, 52, 1507], "text": "billion", "confidence": "Low"}]}, {"boundingBox": [70, 1586, 560, 1586, 560, 1614, 70, 1614], "text": "JOHNSON & JOHNSON 2012 ANNUAL REPORT", "words": [{"boundingBox": [70, 1587, 175, 1588, 175, 1612, 70, 1613], "text": "JOHNSON"}, {"boundingBox": [180, 1588, 198, 1589, 198, 1612, 181, 1612], "text": "&"}, {"boundingBox": [203, 1589, 309, 1589, 310, 1612, 203, 1612], "text": "JOHNSON"}, {"boundingBox": [315, 1589, 362, 1589, 362, 1612, 315, 1612], "text": "2012"}, {"boundingBox": [367, 1589, 465, 1588, 466, 1613, 368, 1612], "text": "ANNUAL"}, {"boundingBox": [470, 1588, 559, 1586, 560, 1614, 471, 1613], "text": "REPORT"}]}, {"boundingBox": [1441, 2130, 1621, 2129, 1621, 2153, 1442, 2155], "text": "P-08506-00041", "words": [{"boundingBox": [1444, 2131, 1620, 2129, 1621, 2154, 1444, 2155], "text": "P-08506-00041"}]}, {"boundingBox": [371, 2157, 1330, 2155, 1331, 2194, 372, 2195], "text": "Source: https://www.industrydocuments.ucsf.edu/docs/gggn0226", "words": [{"boundingBox": [375, 2159, 487, 2159, 486, 2194, 374, 2193], "text": "Source:"}, {"boundingBox": [494, 2159, 1329, 2156, 1330, 2193, 493, 2194], "text": "https://www.industrydocuments.ucsf.edu/docs/gggn0226"}]}]}]}